These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 18957169)

  • 21. Small P-gp modulating molecules: SAR studies on tetrahydroisoquinoline derivatives.
    Colabufo NA; Berardi F; Cantore M; Perrone MG; Contino M; Inglese C; Niso M; Perrone R; Azzariti A; Simone GM; Porcelli L; Paradiso A
    Bioorg Med Chem; 2008 Jan; 16(1):362-73. PubMed ID: 17936633
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Coumarin derivatives with tumor-specific cytotoxicity and multidrug resistance reversal activity.
    Kawase M; Sakagami H; Motohashi N; Hauer H; Chatterjee SS; Spengler G; Vigyikanne AV; Molnár A; Molnár J
    In Vivo; 2005; 19(4):705-11. PubMed ID: 15999537
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis, evaluation of pharmacological activities and quantitative structure-activity relationship studies of a novel group of bis(4-nitroaryl-1,4-dihyropyridine).
    Miri R; Javidnia K; Hemmateenejad B; Tabarzad M; Jafarpour M
    Chem Biol Drug Des; 2009 Feb; 73(2):225-35. PubMed ID: 19207425
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New 1,3-dioxolane and 1,3-dioxane derivatives as effective modulators to overcome multidrug resistance.
    Schmidt M; Ungvári J; Glöde J; Dobner B; Langner A
    Bioorg Med Chem; 2007 Mar; 15(6):2283-97. PubMed ID: 17276076
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Papyriferic acid derivatives as reversal agents of multidrug resistance in cancer cells.
    Xiong J; Taniguchi M; Kashiwada Y; Sekiya M; Yamagishi T; Takaishi Y
    Bioorg Med Chem; 2010 Apr; 18(8):2964-75. PubMed ID: 20363142
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis and 3D-QSAR study of 1,4-dihydropyridine derivatives as MDR cancer reverters.
    Radadiya A; Khedkar V; Bavishi A; Vala H; Thakrar S; Bhavsar D; Shah A; Coutinho E
    Eur J Med Chem; 2014 Mar; 74():375-87. PubMed ID: 24486418
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis of curcumin mimics with multidrug resistance reversal activities.
    Um Y; Cho S; Woo HB; Kim YK; Kim H; Ham J; Kim SN; Ahn CM; Lee S
    Bioorg Med Chem; 2008 Apr; 16(7):3608-15. PubMed ID: 18295490
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reversal effect of Ganoderma lucidum polysaccharide on multidrug resistance in K562/ADM cell line.
    Li WD; Zhang BD; Wei R; Liu JH; Lin ZB
    Acta Pharmacol Sin; 2008 May; 29(5):620-7. PubMed ID: 18430371
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Flavonoid-related modulators of multidrug resistance: synthesis, pharmacological activity, and structure-activity relationships.
    Ferté J; Kühnel JM; Chapuis G; Rolland Y; Lewin G; Schwaller MA
    J Med Chem; 1999 Feb; 42(3):478-89. PubMed ID: 9986718
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Isomeric N,N-bis(cyclohexanol)amine aryl esters: the discovery of a new class of highly potent P-glycoprotein (Pgp)-dependent multidrug resistance (MDR) inhibitors.
    Teodori E; Martelli C; Salerno M; Darghal N; Dei S; Garnier-Suillerot A; Gualtieri F; Manetti D; Scapecchi S; Romanelli MN
    J Med Chem; 2007 Feb; 50(4):599-602. PubMed ID: 17256837
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development of small-molecule P-gp inhibitors of the N-benzyl 1,4-dihydropyridine type: novel aspects in SAR and bioanalytical evaluation of multidrug resistance (MDR) reversal properties.
    Baumert C; Günthel M; Krawczyk S; Hemmer M; Wersig T; Langner A; Molnár J; Lage H; Hilgeroth A
    Bioorg Med Chem; 2013 Jan; 21(1):166-77. PubMed ID: 23199479
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MDR-reversal activity of chalcones.
    Ivanova A; Batovska D; Engi H; Parushev S; Ocsovszki I; Kostova I; Molnar J
    In Vivo; 2008; 22(3):379-84. PubMed ID: 18610751
    [TBL] [Abstract][Full Text] [Related]  

  • 33. N,N-bis(cyclohexanol)amine aryl esters: a new class of highly potent transporter-dependent multidrug resistance inhibitors.
    Martelli C; Alderighi D; Coronnello M; Dei S; Frosini M; Le Bozec B; Manetti D; Neri A; Romanelli MN; Salerno M; Scapecchi S; Mini E; Sgaragli G; Teodori E
    J Med Chem; 2009 Feb; 52(3):807-17. PubMed ID: 19140665
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Conjugated indole-imidazole derivatives displaying cytotoxicity against multidrug resistant cancer cell lines.
    James DA; Koya K; Li H; Chen S; Xia Z; Ying W; Wu Y; Sun L
    Bioorg Med Chem Lett; 2006 Oct; 16(19):5164-8. PubMed ID: 16870446
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Design, synthesis, and calcium channel antagonist activity of new 1,4-dihydropyridines containing 4-(5)-chloro-2-ethyl-5-(4)-imidazolyl substituent.
    Davood A; Mansouri N; Rerza Dehpour A; Shafaroudi H; Alipour E; Shafiee A
    Arch Pharm (Weinheim); 2006 Jun; 339(6):299-304. PubMed ID: 16649160
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Flavonoid dimers as bivalent modulators for p-glycoprotein-based multidrug resistance: structure-activity relationships.
    Chan KF; Zhao Y; Chow TW; Yan CS; Ma DL; Burkett BA; Wong IL; Chow LM; Chan TH
    ChemMedChem; 2009 Apr; 4(4):594-614. PubMed ID: 19288491
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Design, synthesis, and quantitative structure-activity relationship of cytotoxic gamma-carboline derivatives.
    Chen J; Dong X; Liu T; Lou J; Jiang C; Huang W; He Q; Yang B; Hu Y
    Bioorg Med Chem; 2009 May; 17(9):3324-31. PubMed ID: 19359185
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Design and synthesis of tetrahydroisoquinoline derivatives as potential multidrug resistance reversal agents in cancer.
    Li Y; Zhang HB; Huang WL; Li YM
    Bioorg Med Chem Lett; 2008 Jun; 18(12):3652-5. PubMed ID: 18502125
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Docking and QSAR Studies of 1,4-Dihydropyridine Derivatives as Anti- Cancer Agent.
    Mollazadeh S; Shamsara J; Iman M; Hadizadeh F
    Recent Pat Anticancer Drug Discov; 2017; 12(2):174-185. PubMed ID: 28137213
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Design, synthesis, and in vitro activity of catamphiphilic reverters of multidrug resistance: discovery of a selective, highly efficacious chemosensitizer with potency in the nanomolar range.
    Teodori E; Dei S; Quidu P; Budriesi R; Chiarini A; Garnier-Suillerot A; Gualtieri F; Manetti D; Romanelli MN; Scapecchi S
    J Med Chem; 1999 May; 42(10):1687-97. PubMed ID: 10346921
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.